Pages

▼
Friday, January 31, 2025

Denosumab Starts A Phase-I Trial In People With Established T1D

›
Denosumab is a monoclonal antibody, which is already approved for several bone related diseases and is sold under the names Wyost, Xgeva, Pr...
1 comment:
Sunday, January 19, 2025

What To Watch In 2025

›
Last year, at the start of the year, I published a blog of four research projects I was looking forward to updates in the new year.  This ye...
Tuesday, December 31, 2024

Breakthrough T1D (formerly JDRF) Funding for a Cure 2024

›
Normally, sometime in October, I write a summary of all the clinical trials funded by JDRF.   However, this year I didn't, which was a m...
2 comments:
Monday, December 23, 2024

Fenofibrate Is Unsuccessful In A Phase-IIΔ Trial In Honeymooners

›
Fenofibrate (also spelled Phenofibrate) is commonly prescribed for high cholesterol and high triglycerides. In 2017, it was the 70th most co...
1 comment:
Tuesday, November 19, 2024

Encellin Starts a Phase-I Trial of ENC-201-CED (Encapsulated Beta Cells)

›
The company Encellin has started a Phase-I clinical trial to test ENC-201-CED an encapsulated beta cell product. Encapsulated Beta Cells In ...
Friday, November 8, 2024

Frexalimab Starts A Phase-IIΔ Clinical Trial (FABULINUS)

›
There are two good reasons to test Frexalimab as a cure or treatment for Type-1 Diabetes (T1D).  The first is that it has shown some effecti...
Sunday, October 6, 2024

The full story on "Stem cells reverse woman’s diabetes — a world first"

›
If you've been reading news recently you might have seen headlines like these: Stem cells reverse woman’s diabetes — a world first Stem ...